Rafick G. Henein, Ph.D., MBA
Director Since 2007
Pharmaceutical Consultant
Dr. Rafick G. Henein has held various executive positions in the pharmaceutical industry in the Middle East, Europe, Canada and the United States. In Canada, he started his career at Ayerst Laboratories Inc. in 1971 and served as Senior Vice President, Plant and Distribution Operations from 1983 to 1988. He then joined Novopharm Limited (Canada), first as Executive Vice President and, subsequently as President and Chief Operating Officer before being named President and Chief Executive Officer of Novopharm International. In 1997, Dr. Henein joined IVAX Pharmaceuticals, Inc., a leading generic company headquartered in Miami, Florida and served as its President and Chief Executive Officer until its acquisition last year by Teva to form one of the largest pharmaceutical generic companies in the world.
Dr. Henein holds a Ph.D. in pharmaceutical technology from the Academy of Sciences of Hungary and a M.Sc. in pharmaceutical sciences from Budapest University in Hungary. He also has a MBA and a Diploma in Management from McGill University. Dr. Henein is a member of the Ontario College of Pharmacists and the Order of Pharmacists of Québec. |
Stock information
| Symbol |
TSX : BIP |
| Last trade |
0.01 |
| Open |
0.01 |
| Net change |
0.00 |
| High |
0.01 |
| Low |
0.01 |
| 52 week range |
0.01 - 0.25 |
| Volume |
0 |
| As of |
2008-12-03
15:20 EST |
Quotes are delayed. For informational purposes only.
|
